Inventor · disambiguated record
Meenhard Herlyn
Also filed as: HERLYN MEENHARD
12 granted patents·11 pending applications·456 citations·filing 1981–2023
93Inventor score
Top patents by PatentIndex Score
23 records- 0195US4471057ADetection of colorectal carcinomaWISTAR INST·Filed 1981·Granted Sep 11, 1984·103 cites·8 claims
- 0293US4849509AMonoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodiesWISTAR INST·Filed 1987·Granted Jul 18, 1989·90 cites·5 claims
- 0388US5470571AMethod of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425WISTAR INST·Filed 1990·Granted Nov 28, 1995·86 cites·1 claims
- 0482US2024207202A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2023·Application pending·0 cites
- 0579US5622835AWT1 monoclonal antibodiesWISTAR INST·Filed 1994·Granted Apr 22, 1997·41 cites·10 claims
- 0676US7217570B2Organotypic intestinal culture and methods of use thereofWISTAR INST·Filed 2002·Granted May 15, 2007·10 cites·19 claims
- 0773US5633142AWT1 monoclonal antibodies and methods of use thereforWISTAR INST·Filed 1995·Granted May 27, 1997·43 cites·4 claims
- 0872US6486133B1Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermisWISTAR INST·Filed 1998·Granted Nov 26, 2002·46 cites·4 claims
- 0972US2023181489A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2022·Application pending·0 cites
- 1065US7544465B2Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activityWISTAR INST·Filed 2002·Granted Jun 9, 2009·2 cites·49 claims
- 1163US4607009ALewis blood group phenotype assayWISTAR INST·Filed 1983·Granted Aug 19, 1986·17 cites·22 claims
- 1260US2022177548A1Methods and Compositions for Treating MelanomaWISTAR INST·Filed 2021·Application pending·0 cites
- 1359US2018228740A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2016·Application pending·0 cites
- 1457US4786593ADiagnostic method for detection of neural crest diseaseWISTAR INST·Filed 1985·Granted Nov 22, 1988·18 cites·13 claims
- 1552US11208468B2Methods and compositions for treating melanomaWISTAR INST·Filed 2017·Granted Dec 28, 2021·0 cites·14 claims
- 1645US2011177042A1Method for Dedifferentiating MelanocytesHERLYN MEENHARD·Filed 2009·Application pending·0 cites
- 1744US2015166646A1Methods and Compositions for Treating or Diagnosing MelanomaWISTAR INST·Filed 2013·Application pending·0 cites
- 1840US8999706B2Methods for preparation of human hair-follicle derived multipotent adult stem cellsXU XIAOWEI·Filed 2006·Granted Apr 7, 2015·0 cites·2 claims
- 1940US2002165188A1Methods for inhibition of tumorigenic properties of melanoma cellsFiled 2002·Application pending·0 cites
- 2040US2002081711A1Novel genetic suppressor elements and methods of making the sameWISTAR INST·Filed 2001·Application pending·0 cites
- 2138US2004031067A1Regulation of human skin healingFiled 2001·Application pending·0 cites
- 2236US2012164148A1Compositions Containing JARID1B Inhibitors and Methods for Treating CancerROESCH ALEXANDER O·Filed 2010·Application pending·0 cites
- 2335US2021153484A1Humanized Mouse ModelThe Wistar lnstitute·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Meenhard Herlyn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →